Fish oil supplementation in chronic obstructive pulmonary disease: feasibility of conducting a randomised controlled trial.

about

Fish oil supplementation in chronic obstructive pulmonary disease: feasibility of conducting a randomised controlled trial.

Item

http://www.wikidata.org/entity/Q47142770

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Fish oil supplementation in ch ...... a randomised controlled trial.

@en

Fish oil supplementation in ch ...... a randomised controlled trial.

@nl

type

Item

label

Fish oil supplementation in ch ...... a randomised controlled trial.

@en

Fish oil supplementation in ch ...... a randomised controlled trial.

@nl

prefLabel

Fish oil supplementation in ch ...... a randomised controlled trial.

@en

Fish oil supplementation in ch ...... a randomised controlled trial.

@nl

P1476

Fish oil supplementation in ch ...... a randomised controlled trial

@en

P2093

Ashley S Fulton

http://www.w3.org/2001/XMLSchema#string

Lisa G Wood

http://www.w3.org/2001/XMLSchema#string

Manohar L Garg

http://www.w3.org/2001/XMLSchema#string

Peter Frith

http://www.w3.org/2001/XMLSchema#string

Peter R C Howe

http://www.w3.org/2001/XMLSchema#string

P2860

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

Treatment allocation by minimisation

Cachexia: a new definition.

Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study.

Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.

The forced oscillation technique in clinical practice: methodology, recommendations and future developments.

Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and l

Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable.

Sample size calculations for pilot randomized trials: a confidence interval approach.

Feasibility of ω-3 fatty acid supplementation as an adjunct therapy for people with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.

P2888

s40814-017-0211-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40814-017-0211-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alison M. Coates

Marie T Williams

Alison M Hill

P577

2017-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092984286

http://www.w3.org/2001/XMLSchema#string

P698

29209514

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

5702222

http://www.w3.org/2001/XMLSchema#string